<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
<title>Knowledge@Wharton -- Health Economics</title>
<link>http://knowledge.wharton.upenn.edu/</link>
<description>Knowledge@Wharton is an online resource that offers the latest business insights, information, and research from a variety of sources. Content includes analysis of current business trends, interviews with industry leaders and faculty, articles based on the most recent business research, book reviews, conference and seminar reports, and links to other websites.</description>
<language>en-us</language>
<copyright>Copyright (c) 2007 The Wharton School of the University of Pennsylvania</copyright>
<pubDate>Sat, 18 May 2013 00:00:00 EST</pubDate>
<lastBuildDate>Sat, 18 May 2013 01:35:30 EST</lastBuildDate>

<image>
<title>Health Economics -- Knowledge@Wharton</title> 
<url>http://www.wharton.upenn.edu/globals/images/katw_white.gif</url> 
<link>http://Knowledge.wharton.upenn.edu/category.cfm?cid=6</link> 
<width>125</width> 
<height>45</height> 
<description>Knowledge@Wharton Health Economics Research</description> 
</image>

<item>
<title>The Future of Health Care: The Prognosis Is Optimistic</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3240</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3240</guid>

<description>There&amp;rsquo;s cause for optimism about the future of health care, according to panelists who discussed the topic at the Wharton Economic Summit 2013. While the panelists agreed on the enormity of the challenges posed by rising health care costs, increased demand and the need to rein in spending while still being patient-centric, all believed that the outlook for health care would be better by the end of the decade.</description>
<pubDate>Tue, 30 Apr 2013 10:49:10 EST</pubDate>
</item>

<item>
<title>Access or Profits? Drug Patent Rulings in India Fuel the Debate</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3231</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3231</guid>

<description>In India, recent rulings to deny patent protection for drugs manufactured by Western pharmaceutical firms have cast doubt on whether the industry can make a profit in the world&apos;s second-most populous country. They also add fire to the growing debate over whether the industry&apos;s obligation to provide access to life-saving medicine should outweigh its drive for profits. According to experts, the rulings will make pharmaceutical multinationals think twice about their overseas strategies -- particularly with regard to innovative drugs.</description>
<pubDate>Wed, 10 Apr 2013 15:19:46 EST</pubDate>
</item>

<item>
<title>Humana&apos;s CEO on Obamacare: &apos;We&apos;re Concerned About What We Don&apos;t Know&apos;</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3216</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3216</guid>

<description>The Patient Protection and Affordable Care Act -- better known as Obamacare -- was signed into law by President Barack Obama in 2010. Since then, it has generated enormous amounts of debate, controversy and uncertainty. In an interview with Knowledge@Wharton, Bruce Broussard, president and CEO of Humana, the fourth-largest health care insurance group, offers his take on Obamacare and the challenges -- and opportunities -- it presents to health care stakeholders.&lt;em&gt; (Video with transcript)&lt;/em&gt;</description>
<pubDate>Wed, 27 Mar 2013 14:31:41 EST</pubDate>
</item>

<item>
<title>Helping Employees to Be Healthier: How About a Sweepstakes?</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3195</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3195</guid>

<description>In order to design effective wellness programs, most large companies are now asking employees to complete health risk assessments (HRAs) -- questionnaires that ask them to reveal such details as their weight, blood pressure and family history of disease. Experts agree that HRAs can be a useful tool, but only if employees actually bother to fill them out. A recent study co-authored by Wharton health care management professor Kevin Volpp suggests one way to encourage workers to do so.</description>
<pubDate>Wed, 27 Feb 2013 15:13:57 EST</pubDate>
</item>

<item>
<title>Nurse Practitioners Are In -- and Why You May Be Seeing More of Them</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3183</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3183</guid>

<description>Despite continuing protests from some physician groups, the role of nurse practitioners in U.S. health care is expanding and will likely change both the costs and type of care experienced by millions of Americans. Insurers, health care centers and private companies are taking notice.</description>
<pubDate>Wed, 13 Feb 2013 14:55:45 EST</pubDate>
</item>

<item>
<title>RX for Hospital Nurses: Shorter Shifts, Less Burnout</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3173</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3173</guid>

<description>Hospital nurses often work shifts of 12 hours or longer, either by choice or because of pressure from their managers. But what effect do such long hours have on job satisfaction, and equally important, on the quality of patient care? A new research paper -- &amp;quot;The Longer the Shifts for Hospital Nurses, the Higher the Levels of Burnout and Patient Dissatisfaction,&amp;quot; by Amy Witkoski Stimpfel, a research fellow at Penn&apos;s School of Nursing, and two colleagues -- offers some perspectives.</description>
<pubDate>Tue, 29 Jan 2013 15:33:59 EST</pubDate>
</item>

<item>
<title>From Fitbit to Fitocracy: The Rise of Health Care Gamification</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3168</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3168</guid>

<description>These days, anyone with a smartphone can download a variety of games designed to make users healthier, whether that means sticking to an exercise routine, losing weight or managing a chronic illness. While experts have dubbed this trend &amp;quot;the gamification of health care,&amp;quot; it has already presented a unique set of problems, including how to protect consumers&apos; privacy and how to keep users engaged enough to show positive results.</description>
<pubDate>Wed, 16 Jan 2013 15:25:48 EST</pubDate>
</item>

<item>
<title>The Promise -- and Perils -- of Personalized Medicine</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3143</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3143</guid>

<description>Personalized medicine -- the ability to tailor therapies to patients&apos; individual genetic characteristics -- has long been the holy grail of the life sciences industry. The effort has produced a string of recent successes, including European approval of the world&apos;s first gene therapy treatment. While exciting for patients, such advances raise a host of ethical, legal and financial challenges that people working in the field will need to address before personalized medicine can become a thriving business.</description>
<pubDate>Wed, 19 Dec 2012 14:23:46 EST</pubDate>
</item>

<item>
<title>&apos;Multi-tasking Writ Large&apos;: Is Health Care Reform a Prescription for Trouble?</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3120</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3120</guid>

<description>Using two decades of data, Wharton health care professors Lawton R. Burns and Mark V. Pauly recently dissected the cost-cutting component of the Affordable Health Care Act, also known as Obamacare. While the title of their research paper, published in &lt;em&gt;Health Affairs,&lt;/em&gt; was &amp;quot;Accountable Care Organizations May Have Difficulty Avoiding the Failures of Integrated Delivery Networks of the 1990s,&amp;quot; the authors had offered another, shorter title: &amp;quot;Doomed to Fail?&amp;quot;</description>
<pubDate>Wed, 05 Dec 2012 15:03:01 EST</pubDate>
</item>

<item>
<title>Research Roundup: The Individual Mandate&apos;s Impact, Giving and Getting Time, and Advertising&apos;s Effect on Stock Returns</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3042</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3042</guid>

<description>Can a health insurance policy based on an individual mandate be more effective than a tax in expanding coverage to more Americans? How does giving time to others affect a person&apos;s subjective sense of how much time he or she has overall? How does the complicated relationship between advertising and the value of a brand name play out in the stock market? Wharton professors Jonathan Kolstad, Cassie Mogilner and Maria Ana Vitorino, respectively, studied these questions and their impact on the business world in recent research papers.</description>
<pubDate>Tue, 03 Jul 2012 13:27:41 EST</pubDate>
</item>

<item>
<title>The Supreme Court Health Care Ruling: Now What?</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3038</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=3038</guid>

<description>With the Supreme Court&apos;s decision to uphold most of the Affordable Care Act, experts from Wharton and the University of Pennsylvania say a small subset of Americans will see significant changes in their ability to obtain insurance, but the health care system as a whole still has a long way to go.</description>
<pubDate>Thu, 28 Jun 2012 16:35:08 EST</pubDate>
</item>

<item>
<title>Health Care Reform: Life after the Supreme Court Debate</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2981</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2981</guid>

<description>The U.S. Supreme Court recently heard arguments both for and against President Obama&apos;s health care reform initiative, known as the Affordable Care Act. The provision at the center of the legal debate -- the individual mandate -- requires all adults to buy health insurance, either through their employers or by purchasing it themselves. Knowledge@Wharton talked with Wharton professors Scott Harrington, Jonathan Kolstad, Mark Pauly and Arnold Rosoff about the possible outcomes of the court case; the potential implications for businesses and consumers, and ways in which health care delivery in this country can be improved. &lt;em&gt;(Video with transcript)&lt;/em&gt;</description>
<pubDate>Wed, 11 Apr 2012 14:27:58 EST</pubDate>
</item>

<item>
<title>The Creative Destruction of Medicine Will Happen -- If Consumers Demand It</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2970</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2970</guid>

<description>In his new book, &lt;em&gt;The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care&lt;/em&gt;, Eric Topol argues that medicine is set to undergo its biggest shakeup in history, pushed by demanding consumers and the availability of game-changing technology. Topol -- a cardiologist, director of the Scripps Translational Science Institute and co-founder of the West Wireless Health Institute in La Jolla, Calif. -- was recently interviewed for Knowledge@Wharton by C. William Hanson, III, director, surgical intensive care, at the Hospital of the University of Pennsylvania. &lt;em&gt;(Podcast with transcript)&lt;/em&gt;</description>
<pubDate>Wed, 04 Apr 2012 12:57:35 EST</pubDate>
</item>

<item>
<title>Looking for Solutions in a Rapidly Changing Health Care Environment</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2963</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2963</guid>

<description>While the U.S. health care system is not yet on life support, it remains a fragmented and unwieldy structure whose rising costs bear little relation to improvements in access or quality. This is despite the introduction of patient management programs, some restructuring of insurance models, and efforts to adjust incentives for decision making all across the care continuum. But during keynote presentations and panel discussions at Wharton&apos;s 18&lt;sup&gt;th&lt;/sup&gt; Annual Health Care Business Conference, the emphasis was on solutions.</description>
<pubDate>Wed, 28 Mar 2012 16:01:53 EST</pubDate>
</item>

<item>
<title>Concierge Medicine: The Doctor Is (Always) In, If You Pay Enough</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2884</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2884</guid>

<description>For anyone who has ever waited days or weeks to see the doctor, concierge medicine sounds appealing: For an additional fee, patients typically enjoy same-day appointments and 24-hour access, more face time with the doctor and extra preventative care. Doctors who offer concierge medicine say the practice frees them from the constraints imposed by insurance providers and allows them time to give patients the individualized attention they need. Skeptics argue that concierge medicine promotes a two-tiered system, improving health care for a few but worsening it for everyone else.</description>
<pubDate>Tue, 22 Nov 2011 14:27:39 EST</pubDate>
</item>

<item>
<title>How to Encourage People to Become Organ Donors: An Incentive System with Heart</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2854</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2854</guid>

<description>While the decision to register as an organ donor is a difficult one, no one can dispute the tremendous need for such donors. Approximately 110,000 people in the U.S. are waiting for organ transplants, and the donation rate in some states is as low as 7%. Against this backdrop, Wharton professor Judd Kessler and a co-researcher set out to see whether a change in the system -- one that gives priority on waiting lists to those who register as organ donors -- could cause a substantial increase in registration numbers.</description>
<pubDate>Fri, 07 Oct 2011 16:18:25 EST</pubDate>
</item>

<item>
<title>Mystery Diagnosis: An Era of Uncertainty for the Health Care Sector</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2847</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2847</guid>

<description>The U.S. health care sector is experiencing a time of enormous change and uncertainty, from legal challenges to President Obama&apos;s health care reform legislation to the soon-to-open generic markets for several best-selling drugs. The health care industry continues to grapple with how to deliver better care in an efficient, cost-effective way. In a recent presentation, four Wharton health care management professors discussed their research on these and other issues.</description>
<pubDate>Wed, 14 Sep 2011 15:07:07 EST</pubDate>
</item>

<item>
<title>Robert Wood Johnson Foundation&apos;s Risa Lavizzo-Mourey: The Challenges Facing Health Care Reform</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2794</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2794</guid>

<description>The landscape for health care in the U.S. continues to shift since the Obama administration passed the Patient Protection and Affordable Care Act last year. Several questions remain unanswered, including how to expand health coverage, what are the potential minefields for doing so, and what are the best ways to ensure that the system performs well. Meanwhile, Americans are becoming increasingly unhealthy, despite spending more on health care than any other nation. To address these issues, Knowledge@Wharton spoke with Risa Lavizzo-Mourey, president and CEO of the Robert Wood Johnson Foundation, which focuses its efforts on improving the country&apos;s health care. Lavizzo-Mourey will be a speaker at the upcoming Wharton Leadership Conference 2011, which will take place on June 22.&lt;em&gt; &lt;/em&gt;</description>
<pubDate>Wed, 08 Jun 2011 13:24:09 EST</pubDate>
</item>

<item>
<title>In the Health Care Sector, Who Should Choose Which Treatment Is Best?</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2742</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2742</guid>

<description>Each day, workers in the health care field debate the most reliable course of action for treating a particular ailment. As part of U.S. health care reform, new emphasis is being placed on comparative effectiveness research (CER), which pits remedies against one another to determine which is best. A new paper by Wharton professor Scott Harrington warns that the government should avoid developing a monopoly on CER, and offers suggestions for sparking interest from private sector researchers.</description>
<pubDate>Wed, 30 Mar 2011 14:25:28 EST</pubDate>
</item>

<item>
<title>As Goes Massachusetts, So Goes the Nation? How Reform Is Impacting Health Care in the Bay State</title>
<category>Health Economics</category>
<link>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2721</link>
<guid>http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&amp;id=2721</guid>

<description>The U.S. health care system is beginning to feel the effects of landmark reform legislation, although much of the law has yet to be implemented and opponents have persisted in calling for its repeal. But lessons learned in Massachusetts, where a similar program was launched in 2006, indicate that some of the dire predictions about national reform may not come to pass. A new research paper co-authored by Wharton health care management professor Jonathan Kolstad examines mandated insurance coverage and its effect on health care use and patient outcomes in the Bay State, finding that -- at least initially -- broader coverage has not led to dramatic overuse of the system or skyrocketing hospital costs.</description>
<pubDate>Wed, 02 Mar 2011 15:47:44 EST</pubDate>
</item>

</channel>
</rss>
